190
Participants
Start Date
October 1, 2024
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
Ibuprofen 400 mg
Ibuprofen 400 mg tablet
Hyoscine N-Butil Bromide
Hyoscine N-Butil Bromide 10 mg two tablets
placebo
Two tablets
ASST Fatebenefratelli Sacco
OTHER